Processive MedTech Development Services ApS: Financial statements 2023
CVR: 41589604
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Processive MedTech Development Services ApS (CVR 41589604) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,357,766 and a net result of DKK 283,601 compared with DKK 356,577 the year before. That is an increase of 30.4% compared with the year before. Equity in the 2023 report amounted to DKK 538,202. The solvency ratio was 54.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,357,766
- Profit/Loss
- DKK 283,601
- Equity
- DKK 538,202
- Total Assets
- DKK 986,286
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.4 mio. | 284 t. | 538 t. | 2 |
| 2022 | - | 1.8 mio. | 357 t. | 370 t. | 2 |
| 2021 | - | 1.5 mio. | 107 t. | 147 t. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Processive MedTech Development Services ApS
Processive MedTech Development Services ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The management consists of Maria Lund Jensen and Miles Barnaby Gerrard. The company is owned by Isar Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,020,213 and a net result of DKK 333,431 compared with DKK -206,835 the year before. Equity in the 2025 report amounted to DKK 534,798.